GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Darya-Varia Laboratoria Tbk (ISX:DVLA) » Definitions » Cyclically Adjusted Revenue per Share

PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Cyclically Adjusted Revenue per Share : Rp1,730.50 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is PT Darya-Varia Laboratoria Tbk Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

PT Darya-Varia Laboratoria Tbk's adjusted revenue per share for the three months ended in Mar. 2024 was Rp475.256. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is Rp1,730.50 for the trailing ten years ended in Mar. 2024.

During the past 12 months, PT Darya-Varia Laboratoria Tbk's average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-20), PT Darya-Varia Laboratoria Tbk's current stock price is Rp1585.00. PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was Rp1,730.50. PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted PS Ratio of today is 0.92.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Darya-Varia Laboratoria Tbk was 1.63. The lowest was 0.82. And the median was 1.19.


PT Darya-Varia Laboratoria Tbk Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Darya-Varia Laboratoria Tbk Cyclically Adjusted Revenue per Share Chart

PT Darya-Varia Laboratoria Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1,639.35 1,694.50

PT Darya-Varia Laboratoria Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,655.26 1,664.82 1,662.18 1,694.50 1,730.50

Competitive Comparison of PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted PS Ratio falls into.



PT Darya-Varia Laboratoria Tbk Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PT Darya-Varia Laboratoria Tbk's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=475.256/130.6070*130.6070
=475.256

Current CPI (Mar. 2024) = 130.6070.

PT Darya-Varia Laboratoria Tbk Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 238.021 93.015 334.218
201409 299.698 94.576 413.875
201412 254.722 98.819 336.659
201503 306.792 98.388 407.258
201506 294.192 99.766 385.136
201509 281.633 101.037 364.059
201512 287.800 102.133 368.037
201603 339.909 102.764 432.005
201606 345.053 103.212 436.637
201609 346.795 104.142 434.922
201612 268.830 105.222 333.686
201703 356.933 106.476 437.826
201706 353.379 107.722 428.455
201709 378.542 108.020 457.694
201712 323.111 109.017 387.101
201803 385.656 110.097 457.502
201806 344.090 111.085 404.561
201809 379.186 111.135 445.625
201812 414.125 112.430 481.079
201903 431.555 112.829 499.556
201906 386.041 114.730 439.463
201909 446.282 114.905 507.269
201912 356.864 115.486 403.590
202003 431.927 116.252 485.261
202006 396.734 116.630 444.280
202009 314.605 116.397 353.014
202012 490.412 117.318 545.962
202103 435.941 117.840 483.172
202106 434.646 118.184 480.335
202109 532.377 118.262 587.952
202112 294.262 119.516 321.569
202203 577.010 120.948 623.089
202206 390.654 123.322 413.730
202209 396.060 125.298 412.840
202212 347.920 126.098 360.362
202303 458.177 126.953 471.366
202306 418.997 127.663 428.660
202309 327.753 128.151 334.033
202312 483.365 129.395 487.894
202403 475.256 130.607 475.256

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


PT Darya-Varia Laboratoria Tbk  (ISX:DVLA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1585.00/1730.5
=0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of PT Darya-Varia Laboratoria Tbk was 1.63. The lowest was 0.82. And the median was 1.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


PT Darya-Varia Laboratoria Tbk Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of PT Darya-Varia Laboratoria Tbk's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Business Description

Traded in Other Exchanges
N/A
Address
Jalan. R.A. Kartini Kav. 8, 18th-19th Floor, South Quarter, Tower C, Jakarta, IDN, 12430
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, medical and dental equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics; wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory equipment, cosmetic; wholesale trade in pharmaceuticals; laboratory testing services, health support service activities, research and development, periodic inspection services, and many more activities.

PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Headlines

No Headlines